Jonathan A. Speak - Concepedia

Author

Jonathan A. Speak

Dana-Farber Cancer Institute

Also Known As

J A Speak, J Speak, J. SPEAK, JONATHAN A. SPEAK, Jonathan A. Speak

Publications

336

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University

About

Jonathan A. Speak is an author at Dana-Farber Cancer Institute specializing in oncology, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	249
2	Immunology	6	6	249
3	Cell Biology	2	2	64
4	Health Sciences	1	1	10
5	Molecular Medicine	1	1	10

Jonathan A. Speak

Publications

331

Citations

H-Index

Page 1

	Year	Citations
Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. Rolf A. Stahel, M Mabry, Arthur T. Skarin, Journal of Clinical Oncology Murine Monoclonal AntibodyCancer ImmunosurveillanceOncologic ImagingCancer DetectionBone Marrow Metastasis	1985	130
Membrane antigen in small cell carcinoma of the lung defined by monoclonal antibody SM1. Samuel D. Bernal, Jonathan A. Speak PubMed Monoclonal Antibody Sm1Immunocytochemical TechniqueImmunologyPathologyImmunotherapy	1984	52
Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small‐cell carcinoma and squamous‐cell carcinomas Rolf A. Stahel, Jonathan A. Speak, Samuel D. Bernal International Journal of Cancer	1985	36
SQM1 Antiody defines a surface membrane antigen in squamous carcinoma of the head and neck Klaus Boeheim, Jonathan A. Speak, Emil Frei, International Journal of Cancer	1985	30
Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung R. Stahel, Carl O’Hara, M Mabry, Lung Cancer Tumor BiologyCancer ImmunosurveillanceMedicineImmunologyPathology	1987	26
Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung. M Mabry, Jonathan A. Speak, J D Griffin, Journal of Clinical Investigation ImmunologyPathologyImmunotherapyTumor BiologyClonogenic Assays	1985	19
Selective cytotoxicity of murine monoclonal antibody LAM2 against human small‐cell carcinoma in the presence of human complement: Possible use for <i>in vitro</i> elimination of tumor cells from bone marrow Rolf A. Stahel, Mack Mabry, Kert D. Sabbath, International Journal of Cancer	1985	16
Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung. Samuel D. Bernal, Mack Mabry, Rolf A. Stahel, PubMed ImmunologyPathologySelective CytotoxicitySurface MembraneImmunotherapy	1985	12
Molecular analysis in chronic granulocytic leukaemia: location of breakpoints within M-BCR and relationship with presentation platelet counts John Ardern, Jonathan A. Speak, Kate Hyde, Clinical & Laboratory Haematology ImmunohematologyMixed-phenotype Acute LeukemiaImmunologyPathologyMyeloid Neoplasia	2008	10

Page 1